Excretion and metabolism of [14C]aclidinium bromide administered intravenously in healthy subjects

Trial Profile

Excretion and metabolism of [14C]aclidinium bromide administered intravenously in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2012

At a glance

  • Drugs Aclidinium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacokinetics
  • Sponsors Almirall S.A.; Covance; Forest
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top